| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |